台股 » 個股 » 大學光 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

大學光

(3218)
可現股當沖
  • 股價
    224.5
  • 漲跌
    ▼1.0
  • 漲幅
    -0.44%
  • 成交量
    233
  • 產業
    上櫃 生技醫療類股
  • 381人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
大學光 (3218)籌碼相關-元富-吉利 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元富-吉利 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/03/0400.002228.00233.50-2141-1.42%
2025/03/032232.252233.25232.5001390.00%
2025/02/272233.0000.00231.5021381.44%
2025/02/2600.002231.25233.00-2138-1.44%
2025/02/212233.7500.00234.0021391.43%
2025/02/141228.0000.00227.5011470.68%
2025/02/1000.002219.50218.50-2136-1.47%
2025/02/062215.5000.00215.0021341.49%
2025/01/2200.001206.50205.00-1131-0.76%
2025/01/211202.5000.00202.0011320.75%
2025/01/1400.002204.25205.00-2136-1.46%
2025/01/062200.5000.00202.0021451.37%
2024/12/060213.5000.00213.0002850.02%
2024/11/060224.0000.00224.5002940.01%
2024/10/070247.5000.00246.5003570.01%
2024/09/1300.004239.00238.00-4294-1.36%
2024/09/124235.1300.00239.0042931.36%
2024/09/090213.0000.00212.5002620.01%
2024/09/060216.5000.00215.5002710.02%
2024/09/040221.5000.00220.0002800.01%
2024/08/3000.001229.50231.00-1292-0.34%
2024/08/060224.0000.00223.0003690.01%
2024/07/091255.5000.00253.5013830.26%
2024/07/080258.501257.50258.50-1383-0.25%
2024/07/041252.0000.00251.5013840.26%
2024/06/060251.0000.00249.5004870.01%
2024/05/2900.000255.00253.5005150.00%
2024/05/2800.000256.00255.000530-0.01%
2024/05/2000.001265.50268.00-1642-0.16%
2024/05/060251.5000.00251.0006630.01%
2024/04/240243.5000.00245.0006670.00%
2024/04/220241.0000.00236.0006900.00%
2024/04/190.1253.7200.00246.500.16810.02%
2024/04/151268.0000.00267.0016650.15%
2024/04/120270.500.2271.00269.50-0.2658-0.03%
2024/04/080273.0000.00273.0006420.01%
2024/03/2700.003274.33275.50-3633-0.47%
2024/03/262269.0000.00268.5026420.31%
2024/03/2200.000.1276.50275.50-0.1643-0.01%
2024/03/191272.501276.50274.0006390.00%
2024/03/182.1269.7600.00274.002.16280.33%
2024/03/150.1274.0000.00271.000.16170.01%
2024/03/141.3281.0600.00281.001.35990.22%
大學光 相關文章